Iovance Biotherapeutics Undervalued
This is a news story, published by Yahoo Finance, that relates primarily to Amtagvi news.
Amtagvi news
For more Amtagvi news, you can click here:
more Amtagvi newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Iovance Biotherapeutics stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest stock news, independent biopharmaceutical companies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Iovance BiotherapeuticsThe Motley Fool
•Health
Health
Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts
74% Informative
Iovance Biotherapeutics is pioneering a new approach to treating cancer.
The company's first therapy, Amtagvi , is racking up sales, but the stock is down about 88% from a peak it set in 2021 .
The average sell-side analyst who follows the stock thinks it's worth $ 23.77 per share. That consensus target implies a gain of about 280% from recent prices.
The Motley Fool is issuing “ Double Down ” alerts for three incredible companies.
Nvidia , Apple and Netflix are among the companies that you can invest in.
Right now, there may not be another chance like this anytime soon.
You can invest $ 1,000 when we doubled down in 2009 , you’d have $ 369,816 !.
VR Score
66
Informative language
61
Neutral language
25
Article tone
informal
Language
English
Language complexity
46
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
7
Source diversity
2
Affiliate links
no affiliate links
Small business owner?